With the deepening of biomedical research, the role of animal models in disease research, drug screening and therapeutic development has become increasingly prominent. Among them, mouse models have become the most commonly used experimental animals because their biological characteristics are highly similar to those of humans. However, traditional mouse models have obvious limitations in the study of certain human-specific diseases, especially those related to the immune system. In this regard, InnoModels Biotechnology has introduced the MHC (Major Histocompatibility Complex) humanized mouse model, which brings a breakthrough in biomedical research.
The greatest advantage of the MHC humanized mouse model is the high degree of humanization of the immune system, as the MHC region is responsible for encoding the major histocompatibility antigens in mice, which is closely related to the ability of the immune system to recognize "self" and "not-self". Through gene editing technology, InnoModels has successfully replaced the MHC region in mice with the human MHC region, making the immune response of these mice more similar to that of humans.

This highly humanized immune system makes the MHC humanized mouse model more representative for disease research. For example, in the fields of autoimmune diseases, transplant rejection, and infectious diseases, researchers can use these mouse models to more accurately mimic the pathogenesis of human diseases, thus providing a deeper understanding of the disease mechanisms and supporting the development of new therapeutic approaches.
In addition, the application of MHC humanized mouse models in drug discovery and development is also very promising. Since the immune system of these mice is similar to that of humans, the responses and effects of drugs in humans can be better predicted during new drug screening and efficacy assessment, reducing uncertainties and risks in clinical trials.
In summary, the MHC humanized mouse model of InnoModels provides a more realistic and effective tool for biomedical research. Its appearance not only enhances our understanding of human diseases, but also opens new doors for drug development and innovation of therapeutic methods. With the continuous advancement of technology and the expansion of application fields, we have reason to believe that the MHC humanized mouse model will play an even more important role in future biomedical research.